Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma

Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma

(2010) Y. Chen et al.   BLOOD

Immune-Related and Inflammatory Conditions and Risk of Lymphoplasmacytic Lymphoma or Waldenstrom Macroglobulinemia

(2010) S. Y. Kristinsson et al.   JNCI-Journal of the National Cancer Institute

Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data

(2010) Johan Askling et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Targeting B cells in immune-mediated inflammatory disease: A comprehensive review of mechanisms of action and identification of biomarkers

(2010) Thomas Dörner et al.   PHARMACOLOGY & THERAPEUTICS

Treatment strategies for nodal and gastrointestinal follicular lymphoma: Current status and future development

(2010) Takuya Watanabe   WORLD JOURNAL OF GASTROENTEROLOGY

Routes to total joint replacement surgery: Patients' and clinicians' perceptions of need

(2010) Anna Sansom et al.   ARTHRITIS CARE & RESEARCH

Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry

(2009) X Mariette et al.   ANNALS OF THE RHEUMATIC DISEASES

Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis

(2009) Thomas Dörner et al.   AUTOIMMUNITY REVIEWS

Antiphospholipid antibodies and malignancies

(2009) A. Tincani et al.   AUTOIMMUNITY REVIEWS

Secondary tumours in Sjögren's syndrome

(2009) László Kovács et al.   AUTOIMMUNITY REVIEWS

Malignancies in systemic lupus erythematosus

(2009) Emese Kiss et al.   AUTOIMMUNITY REVIEWS

Malignancy in systemic lupus erythematosus: what have we learned?

(2009) Sasha Bernatsky et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research

(2009) Alexandra Smith et al.   BRITISH JOURNAL OF HAEMATOLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas

(2009) R. J. Bende et al.   HAEMATOLOGICA

Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies

(2009) S. Y. Kristinsson et al.   HAEMATOLOGICA

Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies

(2009) Lesley A. Anderson et al.   INTERNATIONAL JOURNAL OF CANCER

Humanized Anti-CD20 Antibody, Veltuzumab, in Refractory/Recurrent Non-Hodgkin's Lymphoma: Phase I/II Results

(2009) Franck Morschhauser et al.   JOURNAL OF CLINICAL ONCOLOGY

B-cell-depletion therapy in SLE—what are the current prospects for its acceptance?

(2009) Catarina Favas et al.   Nature Reviews Rheumatology

Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma

(2008) Lene Mellemkjaer et al.   ARTHRITIS AND RHEUMATISM

Classification of lymphoid neoplasms: the microscope as a tool for disease discovery

(2008) E. S. Jaffe et al.   BLOOD

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium

(2008) K. Ekstrom Smedby et al.   BLOOD

Autoimmunity and lymphomagenesis

(2008) Lynn R. Goldin et al.   INTERNATIONAL JOURNAL OF CANCER

Editorial: Is BAFF the murderer in lupus?

(2008) P Youinou   LUPUS

The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study

(2007) S Bernatsky et al.   ANNALS OF THE RHEUMATIC DISEASES

Epstein-Barr virus and Burkitt lymphoma

(2007) G Brady et al.   POSTGRADUATE MEDICAL JOURNAL